The amniotic membrane can be described as the innermost layer of the placenta with a width of 0.02-0.05 mm. The two key categories using amniotic membrane includes the management of wounds and biological bandage for the treatment. It is also widely used in the treatment of a range of diseases such as eye surface disorders, corneal degeneration, ocular dystrophy, eyelid reconstruction, bacterial keratitis, corneal ulcers, cataract, glaucoma, bullous keratopathy, among others. Demand for the amniotic membrane has increased, owing to the rising number of non-communicable disease patients.
According to a study, “The Global Amniotic Membrane Market to reach USD 2.9 Billion in 2026” the key companies operating in the global amniotic membrane market are Alliqua BioMedical, Inc., Applied Biologics LLC, Amnio Technology, LLC, Human Regenerative Technologies, LLC, Katena Products, Inc., MiMedx Group, Inc., DermaSciences, Skye Biologics, Inc., Organogensis, Inc. and Amniox Medical, Inc. Majority of these key companies have a well-established portfolio and have sturdy collaborations with tissue banks & hospitals to ensure placental donations. Almost all of these key players are accredited by the American Association for Tissue Banks (AATB) to provide quality or sterile products. These factors thus are likely to aid in the growth of the market over the forecast period.
Based on application, the amniotic membrane market is segmented as ophthalmology, surgical wounds, regenerative medicines, stem cell biology, prenatal diagnosis, and others. Based on enzyme, the market is segmented as Lyophilization Amniotic Membrane and Cryopreserved Amniotic Membrane. The cryopreserved segment dominated the market due to its high effectiveness and usage. In addition, based on end-user, the market is segmented as ambulatory surgical centers, hospitals, research centers & laboratory and specialized clinics. Research centers & laboratory segment is estimated to witness higher growth rate due to the increase in research & development (R&D) investments by major market players and hospitals to appreciate the possible product applications during the forecast period.
The amniotic membrane market is driven by an increase in the number of surgeries being performed across the world, followed by growth in R&D investments in the field of stem cell & regenerative medicine, a rise in disease awareness, and an increase in the aging patient population. However, lack of awareness and stringent rules as well as regulation may impact the market. Moreover, government initiative regarding the treatment of diseases and rise in demand from emerging economies such as China, India, among others, is a key opportunity for the market. Furthermore, growth in technology advancements regarding the amniotic membrane is a major trend for the global market.
Based on geography, the European region dominates the global amniotic membrane market owing to the increase in the prevalence of cicatricial pemphigoid and stevens-johnson syndrome, pterygium, and ocular surface reconstruction in European patients with chemical & thermal burns in the region. Whereas, the Asian-Pacific and North-American regions are anticipated to witness a higher growth rate due to the increase in the number of reconstruction procedures & cosmetic surgeries coupled with rising in the number of surgeries over the forecast period. It is predicted that the global amniotic membrane market will be reached at the US $2.9 billion by 2026.
For More Information on the Research Report, refer to below links: –
Global Amniotic Membrane Market Growth
Related Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
